2026 US Prior Authorization Criteria • UnitedHealthcare

UnitedHealthcare Prior Authorization Guide for Qulipta (atogepant)

Policy Reference: UnitedHealthcare Commercial (2026 Policy P 2146-15) (Oral Gepant (Preventive))

≥4 MMD
Episodic Monthly Threshold
2 classes
Step-Therapy Failures
60 days
Min Trial Per Preventive
≥50% MMD
Or -5 HIT-6 for Renewal

2026 US State Statutory Step-Therapy Overrides

StateStatutory CitationOverride Summary
CACal. Health & Safety Code § 1367.206 / Ins. Code § 10123.201State-regulated California plans must grant expeditious step-therapy exception (within 72h; 24h urgent) when required oral preventives are contraindicated, expected to be ineffective, or previously failed.
CTConn. Gen. Stat. § 38a-510State-regulated Connecticut plans cannot require step-therapy duration exceeding 30 days before granting override upon inadequate response.
KYKy. Rev. Stat. § 304.17A-163State-regulated Kentucky plans cap required step-therapy trial windows and mandate clear override pathways for prior preventive failure or contraindication.
MSMiss. Code Ann. § 83-9-36State-regulated Mississippi plans cap required step-therapy duration at 30 days.
NYN.Y. Ins. Law § 4902 / Pub. Health Law § 4902State-regulated New York plans must accept prior documented preventive failure even if completed under a previous insurer.
TXTex. Ins. Code § 1369.0546State-regulated Texas plans must grant step-therapy override when prerequisite drugs are contraindicated or previously discontinued due to adverse events or inefficacy.
IL215 ILCS 5/155.36State-regulated Illinois plans must honor statutory step-therapy exceptions within 72 hours (24 hours urgent).

Note for Prescribing Clinician: State statutory step-therapy protections apply to state-regulated fully insured plans; self-funded ERISA employer plans may enforce full formulary step-therapy tables documented below.